Target intelligence / Profile preview

40S ribosomal subunit (40S)

Target
40S
Molecular classification
Ribonucleoprotein complex, Ribosome subunit
01

Overview

The 40S ribosomal subunit is the smaller component of the eukaryotic 80S ribosome, playing a fundamental role in the initiation and accuracy of protein translation (NCBI, 2023). It consists of the 18S ribosomal RNA (rRNA) and approximately 33 ribosomal proteins (RPS), which together form the framework for mRNA binding and tRNA selection (UniProt, 2024). During translation initiation, the 40S subunit binds to the mRNA 5' cap and scans for the AUG start codon, a process regulated by various eukaryotic initiation factors (eIFs). Beyond its role in mature ribosomes, the assembly of pre-40S particles in the nucleolus is a complex, highly regulated process essential for cellular growth and proliferation (PubMed, 2022). Mutations in the proteins or assembly factors of the 40S subunit lead to ribosomopathies, such as Diamond-Blackfan anemia and 5q- syndrome, characterized by bone marrow failure and increased cancer risk (NIH, 2023). Furthermore, many viruses, including Hepatitis C and Poliovirus, hijack the 40S subunit via Internal Ribosome Entry Sites (IRES) to bypass host translation controls (Wikipedia, 2024). While most clinical antibiotics target bacterial ribosomes, the 40S subunit is a target for specific toxins and experimental anti-tumor agents like emetine and pactamycin, which inhibit translation by interfering with the decoding site or translocation (PubChem, 2024).

Other names
Small ribosomal subunit40S subunitPre-40S ribosomal particle40S ribonucleoprotein complex18S ribosomal subunitEukaryotic small ribosomal subunit
02

Mechanism of action

Inhibition of translation initiation by preventing mRNA scanning or eIF recruitment; interference with aminoacyl-tRNA binding at the A-site; blockage of the translocation step during elongation (PubChem, 2024; PubMed, 2022).

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingRibosome biogenesis
04

Disease associations

CancerDiamond-Blackfan anemia5q- syndromeViral infection
05

Safety considerations

Severe systemic toxicity (PubMed, 2023)Cardiotoxicity (PubChem, 2024)Myelosuppression (NIH, 2023)Gastrointestinal distressOff-target mitochondrial ribosome inhibition
06

Interacting drugs

Emetine

3 more in the full profile.

07

Biomarkers

RPS19 mutation status (NIH, 2023)18S rRNA levels (PubMed, 2022)p53 expression levels (PubMed, 2023)Nucleolar morphology

Beyond the preview

Go deeper on 40S ribosomal subunit (40S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 40S ribosomal subunit (40S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call